CN105031744B - 一种增生性瘢痕用微针及其制备方法 - Google Patents
一种增生性瘢痕用微针及其制备方法 Download PDFInfo
- Publication number
- CN105031744B CN105031744B CN201510367351.0A CN201510367351A CN105031744B CN 105031744 B CN105031744 B CN 105031744B CN 201510367351 A CN201510367351 A CN 201510367351A CN 105031744 B CN105031744 B CN 105031744B
- Authority
- CN
- China
- Prior art keywords
- solution
- polymer
- micropin
- preparation
- mould
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 231100000241 scar Toxicity 0.000 title claims abstract description 49
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 39
- 230000002390 hyperplastic effect Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 57
- 229920000642 polymer Polymers 0.000 claims abstract description 45
- 239000002904 solvent Substances 0.000 claims abstract description 33
- 238000011049 filling Methods 0.000 claims abstract description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 56
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 18
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 229920001519 homopolymer Polymers 0.000 claims description 6
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 239000004632 polycaprolactone Substances 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- 239000004425 Makrolon Substances 0.000 claims description 3
- 229920000388 Polyphosphate Polymers 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000001205 polyphosphate Substances 0.000 claims description 3
- 235000011176 polyphosphates Nutrition 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- -1 pentyl ester Chemical class 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 239000000243 solution Substances 0.000 description 89
- 210000001519 tissue Anatomy 0.000 description 26
- 239000000919 ceramic Substances 0.000 description 19
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000000227 grinding Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 238000011068 loading method Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000003463 hyperproliferative effect Effects 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910021421 monocrystalline silicon Inorganic materials 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 229920006125 amorphous polymer Polymers 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510367351.0A CN105031744B (zh) | 2015-06-29 | 2015-06-29 | 一种增生性瘢痕用微针及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510367351.0A CN105031744B (zh) | 2015-06-29 | 2015-06-29 | 一种增生性瘢痕用微针及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105031744A CN105031744A (zh) | 2015-11-11 |
CN105031744B true CN105031744B (zh) | 2018-01-02 |
Family
ID=54439094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510367351.0A Active CN105031744B (zh) | 2015-06-29 | 2015-06-29 | 一种增生性瘢痕用微针及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105031744B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017164405A1 (ja) * | 2016-03-25 | 2017-09-28 | 凸版印刷株式会社 | 経皮投与デバイス |
CN107334495A (zh) | 2017-08-24 | 2017-11-10 | 广州新诚生物科技有限公司 | 用于植发的可溶针以及其制作方法 |
CN108619079A (zh) * | 2018-04-18 | 2018-10-09 | 苏州德锐特成像技术有限公司 | 一种治疗瘢痕疙瘩的微针贴片及试剂盒与应用 |
CN111558128A (zh) * | 2019-03-26 | 2020-08-21 | 华中科技大学同济医学院附属协和医院 | 一种载瘢痕修复药物的可溶性微针阵列及制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250066A (en) * | 1990-03-19 | 1993-10-05 | Becton Dickinson And Company | Plastic pointed articles and method for their preparation |
CN101297989B (zh) * | 2008-06-19 | 2010-06-23 | 上海交通大学 | 基于模压的中空微针批量制备方法 |
EP2346563B1 (en) * | 2008-10-07 | 2018-08-29 | Tuo Jin | Phase-transition polymeric microneedles |
JP2011012050A (ja) * | 2009-06-03 | 2011-01-20 | Bioserentack Co Ltd | 多孔性基盤を用いたマイクロニードル・アレイとその製造方法 |
CN103568160B (zh) * | 2012-07-27 | 2015-11-04 | 中国科学院理化技术研究所 | 一种聚合物材料微针阵列贴片的制作方法 |
JP2016528971A (ja) * | 2013-07-22 | 2016-09-23 | ジン, トゥオJin, Tuo | 相転移マイクロニードルパッチの調製過程 |
-
2015
- 2015-06-29 CN CN201510367351.0A patent/CN105031744B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105031744A (zh) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105031744B (zh) | 一种增生性瘢痕用微针及其制备方法 | |
JP4427691B2 (ja) | マイクロニードルアレイ | |
CN108785244B (zh) | 一种担载疏水药物的可溶性微针及其制备方法 | |
US7347835B2 (en) | Process for producing pad base for endermism, and pad base for endermism, and injection needle | |
JP2005021677A (ja) | 経皮投薬用パッドベース、及び注射針 | |
US11801373B1 (en) | Insoluble transdermal microneedle patch, and preparation method therefor and application thereof | |
CN105013075A (zh) | 一种底座式微针阵列及其制备方法 | |
JP2005021678A (ja) | 経皮投薬用パッドベースの製造方法及び経皮投薬用パッドベース、並びに注射針 | |
CN1805714A (zh) | 从皮肤被染色区域除去色料的方法 | |
CN113230388A (zh) | 含胰岛素负载的苯硼酸基ε-聚赖氨酸的微针贴及制备方法 | |
JP2005152180A (ja) | インスリン投与用マイクロニードル | |
CN115227636A (zh) | 一种负载bsh的可溶性微针透皮给药系统及其制备方法与应用 | |
KR20220151995A (ko) | 리라글루타이드를 함유하는 마이크로니들 제조용 조성물 | |
WO2022193975A1 (zh) | 供注射用罗哌卡因长效溶液制剂及其制备方法 | |
CN107233296A (zh) | 胸腺五肽可溶性微针及其制备方法 | |
CN114948852B (zh) | 一种用于脑部疾病诊断和治疗的微针系统及其制备方法 | |
CN110101660A (zh) | 一种包含有地佐辛与利卡多因的复方药物缓释制剂及其制备方法 | |
JP5672554B2 (ja) | 皮下又は経皮吸収用組成物 | |
CN103446041B (zh) | 一种亮丙瑞林缓控释药棒及其制备方法 | |
CN109925297A (zh) | 含乌头碱的经皮给药系统及其制备方法和应用 | |
KR102494544B1 (ko) | 소아마비 백신 전달용 용해성 미세바늘 패치 | |
CN110101865A (zh) | 一种包含有地佐辛药物缓释制剂及其制备方法 | |
CN116440062B (zh) | 一种搭载左西孟旦用于治疗心力衰竭的可溶性微针贴片及其制备方法 | |
CN118141744A (zh) | 一种用于治疗肌少症的载药微针及其制备方法 | |
CN115192511A (zh) | 水溶性微针及其制备方法、微针贴片和透皮给药系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171127 Address after: Suzhou City, Jiangsu province 215123 Xiangcheng District Ji Road No. 8 Applicant after: Soochow University Address before: Zhangjiagang mayor Jingyang Road Suzhou City, Jiangsu province 215600 No. 10 Applicant before: Zhangjiagang Institute of Industrial Technologies Soochow University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220113 Address after: 201914 room d3-969, No. 58 Fumin Branch Road, Hengsha Township, Chongming District, Shanghai (Shanghai Hengtai Economic Development Zone) Patentee after: Shanghai Huikang Health Technology Center Address before: 215123 No. 8 Jixue Road, Xiangcheng District, Suzhou City, Jiangsu Province Patentee before: SOOCHOW University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220303 Address after: 202156 No. 825, Xinkaihe Road, Xinhe Town, Chongming District, Shanghai (Shanghai Xinhe economic community) Patentee after: Shanghai antuopuruo Technology Development Center Address before: 201914 room d3-969, No. 58 Fumin Branch Road, Hengsha Township, Chongming District, Shanghai (Shanghai Hengtai Economic Development Zone) Patentee before: Shanghai Huikang Health Technology Center |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230403 Address after: Room 128, 2nd Floor, 8802, Zone C, Walker Park, Hainan Ecological Software Park, Old Town High tech Industry Demonstration Zone, Chengmai County, Hainan Province, 571924 Patentee after: Hainan Dramick Investment Co.,Ltd. Address before: 202156 No. 825, Xinkaihe Road, Xinhe Town, Chongming District, Shanghai (Shanghai Xinhe economic community) Patentee before: Shanghai antuopuruo Technology Development Center |
|
TR01 | Transfer of patent right |